全面应对耐多药结核病的挑战 ——问题、困惑、行动和希望

doi:10.3969/j.issn.1006⁃5725.2022.13.001

实用医学杂志 ›› 2022, Vol. 38 ›› Issue (13): 1573-1577.doi: 10.3969/j.issn.1006⁃5725.2022.13.001

• 述评 • 下一篇

全面应对耐多药结核病的挑战 ——问题、困惑、行动和希望

刘志辉1 钟球2

1 广州市胸科医院（广州 510095）；2 广东省结核病控制中心（广州 510630）

出版日期:2022-07-10 发布日期:2022-07-10
通讯作者: 钟球 E⁃mail：zhongqiu@vip.163.com

Comprehensive response the challenge to multidrug ⁃ resistant tuberculosis ⁃ problems，confusions，actions and wishes

LIU Zhihui*，ZHONG Qiu.

Guang Zhou Chest Hospital，Guangzhou 510095，China

Online:2022-07-10 Published:2022-07-10
Contact: ZHONG Qiu E⁃mail：zhongqiu@vip.163.com

摘要/Abstract

摘要：

耐多药结核病发病率高、病死率高、治疗费用高、治愈率低，是 2035 年 WHO 全球终止结核病目标的巨大障碍。我国作为耐多药结核病高负担国家，防控形势尤为严峻。本文拟从诊断、治疗和防控策略等方面浅谈耐多药结核病控制中的问题与困惑以及突破严峻形势的着力点。

关键词:

耐多药结核病, 结核病控制

Abstract:

Multidrug⁃resistant tuberculosis（MDR⁃TB）which characterized by high morbidity，high mor⁃ tality，high treatment cost and low cure rate is a huge obstacle to the WHO goal of ending TB globally by 2035. As the the second country with a high burden of MDR⁃TB ，the situation of prevention and control is even more severe. This paper tries to discuss the problems and confusions in the control of MDR ⁃TB from the aspects of diagnosis， treatment，prevention and control strategies，as well as the focus of our desire to make breakthroughs.

Key words:

multidrug?resistant tuberculosis, tuberculosis control

刘志辉钟球.

全面应对耐多药结核病的挑战 ——问题、困惑、行动和希望 [J]. 实用医学杂志, 2022, 38(13): 1573-1577.

LIU Zhihui, ZHONG Qiu.. Comprehensive response the challenge to multidrug ⁃ resistant tuberculosis ⁃ problems，confusions，actions and wishes[J]. The Journal of Practical Medicine, 2022, 38(13): 1573-1577.

全面应对耐多药结核病的挑战 ——问题、困惑、行动和希望

Comprehensive response the challenge to multidrug ⁃ resistant tuberculosis ⁃ problems，confusions，actions and wishes

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价